BIOFARM
96 articole · RSS
Biofarm Forecasts 2013's Sales Up 10%, To RON115M
Romanian drug maker Biofarm (BIO.RO) Friday said it forecasts 10% higher sales in 2012, to 115.1 million lei (EUR26.2 million), from RON105 million a year before.
Biofarm Proposes 30% Higher Dividend For 2012
The managing board of Romanian drug maker Biofarm (BIO.RO) Thursday proposed paying out its shareholders dividends of 14.2 million lei (EUR3.2 million) from the profit registered in 2012, up...
Biofarm 2012 Net Profit Up 48% To RON21M
Romanian drugmaker Biofarm (BIO.RO) Friday said its net profit rose 48% to 21.04 million lei (EUR4.8 million) in 2012, boosted by a 12.3% increase in sales.
Biofarm Net Profit Rises To RON17.3M In January-September
Romanian drugmaker Biofarm (BIO.RO) Monday said its net profit rose 26.2% to 17.35 million lei (EUR3.9 million) in the first nine months, helped by higher sales.
Biofarm 1H Profit Up 11% To RON12M
Romanian drugmaker Biofarm (BIO.RO) Tuesday said its net profit in the first half of the year grew by 11.4%, to 12.27 million (EUR2.8 million).
Biofarm 1Q Net Profit Up 8% To RON8.2M
Romanian drugmaker Biofarm (BIO.RO) Monday said its net profit rose 8.1% to 8.2 million lei (EUR1.85 million) in the first quarter, as costs decreased faster than revenues.
Biofarm Sees 2012 Net Profit Up 17% To RON16.6M
Romanian drugmaker Biofarm (BIO.RO) estimates its net profit will rise 17% on the year to 16.6 million lei (EUR3.79 million) in 2012, fueled by higher sales.
Biofarm Set To Double Dividend
Romanian drugmaker Biofarm (BIO.RO) Tuesday proposed paying out a gross dividend of 0.01 lei (EUR0.002) a share from the 2011 profit, nearly double of the year.
Biofarm Emerges As Most Profitable Pharma Company On Bucharest Bourse
Biofarm (BIO.RO) was the most profitable pharmaceuticals company on the Bucharest stock exchange last year. Despite a two-percentage point drop in net profit margin to 15.5%, the drugmaker s...